サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1319020

コンシューマーヘルスケア市場：製品別、流通別-2023-2030年の世界予測

Consumer Healthcare Market by Product, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.76円
コンシューマーヘルスケア市場：製品別、流通別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のコンシューマーヘルスケア市場は、2023年にCAGR 7.34%で3,330億3,000万米ドルと予測され、2030年には驚異的な5,483億1,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のコンシューマーヘルスケア市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.コンシューマーヘルスケアの世界市場規模および予測は？

2.予測期間中、世界のコンシューマーヘルスケア市場を形成するCOVID-19の阻害要因と影響は？

3.コンシューマーヘルスケアの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.コンシューマーヘルスケアの世界市場における競争戦略は？

5.コンシューマーヘルスケアの世界市場における技術動向と規制の枠組みは？

6.コンシューマーヘルスケアの世界市場における主要ベンダーの市場シェアは？

7.コンシューマーヘルスケアの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 高齢者人口の増加と消費者のセルフメディケーション製品への傾向
      • ヘルスケアへのアクセスを手頃な価格で改善するための政府の支援
      • プライベートブランドコンシューマーヘルスケア商品の採用の増加
    • 抑制要因
      • 医薬品有効成分を欠いた偽造品の入手可能性
    • 機会
      • 健康薬と予防薬の承認率の向上
      • オンライン薬局の急速な成長とオンラインプラットフォームによる可用性の向上
    • 課題
      • コンシューマーヘルスケア製品の乱用および誤用に関連する懸念
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 コンシューマーヘルスケア市場：製品別

  • 栄養補助食品
  • 一般用医薬品

第7章 コンシューマーヘルスケア市場配信別

  • 百貨店
  • 独立小売業者
  • 薬局またはドラッグストア
  • 専門小売店
  • スーパーマーケットまたはハイパーマーケット

第8章 南北アメリカのコンシューマーヘルスケア市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のコンシューマーヘルスケア市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのコンシューマーヘルスケア市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 6. CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CONSUMER HEALTHCARE MARKET DYNAMICS
  • FIGURE 8. CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CONSUMER HEALTHCARE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CONSUMER HEALTHCARE MARKET SIZE, BY OTC PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 8. CONSUMER HEALTHCARE MARKET SIZE, BY DEPARTMENTAL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONSUMER HEALTHCARE MARKET SIZE, BY INDEPENDENT RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES OR DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONSUMER HEALTHCARE MARKET SIZE, BY SPECIALIST RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS OR HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. CONSUMER HEALTHCARE MARKET LICENSE & PRICING
目次
Product Code: MRR-433AB1DC2920

The Global Consumer Healthcare Market is forecasted to grow significantly, with a projected USD 333.03 billion in 2023 at a CAGR of 7.34% and expected to reach a staggering USD 548.31 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Consumer Healthcare Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Consumer Healthcare Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Dietary Supplements and OTC Pharmaceuticals. The OTC Pharmaceuticals commanded largest market share of 51.34% in 2022, followed by Dietary Supplements.

Based on Distribution, market is studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets. The Pharmacies or Drugstores commanded largest market share of 46.45% in 2022, followed by Supermarkets or Hypermarkets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.30% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Consumer Healthcare Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Consumer Healthcare Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Consumer Healthcare Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Consumer Healthcare Market?

4. What is the competitive strategic window for opportunities in the Global Consumer Healthcare Market?

5. What are the technology trends and regulatory frameworks in the Global Consumer Healthcare Market?

6. What is the market share of the leading vendors in the Global Consumer Healthcare Market?

7. What modes and strategic moves are considered suitable for entering the Global Consumer Healthcare Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Consumer Healthcare Market, by Product, 2022 vs 2030
  • 4.3. Consumer Healthcare Market, by Distribution, 2022 vs 2030
  • 4.4. Consumer Healthcare Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
      • 5.1.1.2. Government support to offer affordable and improved access to healthcare
      • 5.1.1.3. Growing adoption of private labels consumer healthcare products
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approval rate of wellness and preventive medicines
      • 5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Consumer Healthcare Market, by Product

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. OTC Pharmaceuticals

7. Consumer Healthcare Market, by Distribution

  • 7.1. Introduction
  • 7.2. Departmental Stores
  • 7.3. Independent Retailers
  • 7.4. Pharmacies or Drugstores
  • 7.5. Specialist Retailers
  • 7.6. Supermarkets or Hypermarkets

8. Americas Consumer Healthcare Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Consumer Healthcare Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Consumer Healthcare Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Merger & Acquisition
      • 11.3.1.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
      • 11.3.1.2. Cipla Health to buy nutritional supplement brand Endura Mass
      • 11.3.1.3. Orkla Health acquires Healthspan
    • 11.3.2. Agreement, Collaboration, & Partnership
      • 11.3.2.1. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
      • 11.3.2.2. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
    • 11.3.3. New Product Launch & Enhancement
      • 11.3.3.1. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
      • 11.3.3.2. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
      • 11.3.3.3. Amway India launches nutrition supplements in gummies and jelly strips
    • 11.3.4. Investment & Funding
      • 11.3.4.1. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
    • 11.3.5. Award, Recognition, & Expansion
      • 11.3.5.1. Bayer launches Consumer Health division in India

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing